TP53 and glioblastoma: Conversely, PDGFR amp/gain, CDK4 gain, and TP53 hemizygous deletion were more frequently observed in TERTp wild-type GBM (P = .001, P = .012, and P = .001, respectively, Figure 2 and Table 1).